Pharma's new 'Berlin Declaration' seeks to reserve vaccines, therapeutics in production for low-income countries
As Pfizer/BioNTech and Moderna remain reluctant to share IP or provide tech transfer to expand the manufacture of their life-saving mRNA vaccines for Covid-19, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
